NeoGenomics, Inc. Line of Credit, Current
NeoGenomics, Inc. (NEO) had Line of Credit, Current of $8.87 million as of 2015-12-31, per its 10-K filed 2017-03-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:LinesOfCreditCurrent · last filed 2017-03-14
- 2015-12-31: Line of Credit, Current $8.87M.
- 2014-06-30: Line of Credit, Current $1.99M.
- 2014-03-31: Line of Credit, Current $4.86M.
- 2013-12-31: Line of Credit, Current $4.28M.
| Period end | Line of Credit, Current |
|---|---|
| 2015-12-31 | $8.87M 10-K · filed 2017-03-14 |
| 2014-06-30 | $1.99M 10-Q · filed 2014-07-29 |
| 2014-03-31 | $4.86M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $4.28M 10-K · filed 2015-03-03 |
| 2013-09-30 | $2.74M 10-Q · filed 2013-10-30 |
| 2013-06-30 | $3.19M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $4.19M 10-Q · filed 2013-05-13 |
| 2012-12-31 | $8.46M 10-K · filed 2014-02-24 |
| 2012-09-30 | $8.04M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $6.39M 10-Q/A · filed 2012-08-15 |
| 2012-03-31 | $6.69M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $3.90M 10-K · filed 2013-02-21 |
| 2011-09-30 | $4.47M 10-Q · filed 2011-10-25 |
| 2011-06-30 | $3.82M 10-Q/A · filed 2011-08-01 |
| 2010-12-31 | $3.44M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |